Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins

Journal of General Virology

Volumn 80, Issue 3, 1999, Pages 671-679

  Sanz Parra, A ^a   Vazquez, B ^a   Sobrino, F ^a,b   Cox, S J ^c   Ley, V ^a   Salt, J S ^c,d  

^a INIA   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; COMPLEMENTARY DNA; LIVE VACCINE; RECOMBINANT VACCINE; STRUCTURAL PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANTIBODY RESPONSE; ARTICLE; CATTLE; DNA TRANSFECTION; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; OROPHARYNX; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS CAPSID;

EID: 0033022019     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-3-671     Document Type: Article

References (52)

1. Abrams, C. C., King, A. M. & Belsham, G. J. (1995). Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. Journal of General Virology 76, 3089-3098.
2. Babiuk, L. A., van Drunen Littel-van den Hurk, S., Tikoo, S. K., Lewis, P. J. & Liang, X. (1996). Novel viral vaccines for livestock. Veterinary Immunology and Immunopathology 54, 355-363.
3. 24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence. Journal of General Virology 77, 1011-1018.
4. Barteling, S. J. & Vreeswijk, J. (1991). Developments in foot-and-mouth disease vaccines. Vaccine 9, 75-88.
5. Bett, A. J., Prevec, L. & Graham, F. L. (1993). Packaging capacity and stability of human adenovirus type 5 vectors. Journal of Virology 67, 5911-5921.
6. Bittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G. & Lerner, R. A. (1982). Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298, 30-33.
7. Brown, F. (1988). Use of peptides for immunization against foot-and-mouth disease. Vaccine 6, 180-182.
8. Brown, F. (1995). Antibody recognition and neutralization of foot-and-mouth disease virus. Seminars in Virology 6, 243-248.
9. Chengalvala, M. V., Bhat, B. M., Bhat, R., Lubeck, M. D., Mizutani, S., Davis, A. R. & Hung, P. P. (1994). Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs. Journal of General Virology 75, 125-131.
10. Collen, T. (1994). Foot-and-mouth disease (Aphthovirus): viral T cell epitopes. In Cell-mediated Immunity in Ruminants, pp. 173-197. Edited by B. M. L. Goddeevis & I. Morrison. Boca Raton, FL: CRC Press.
11. Doel, T. R., Williams, L. & Barnett, P. V. (1994). Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 12, 592-600.
12. Domingo, E., Davila, M. & Ortin, J. (1980). Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene 11, 333-346.
13. Ertl, H. C. & Xiang, Z. (1996). Novel vaccine approaches. Journal of Immunology 156, 3579-3582.
14. Falk, M. M., Grigera, P. R., Bergmann, I. E., Zibert, A., Multhaup, G. & Beck, E. (1990). Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. Journal of Virology 64, 748-756.
15. Ferris, N. P. & Dawson, M. (1988). Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases. Veterinary Microbiology 8, 249-256.
16. Gallichan, W. S., Johnson, D. C., Graham, F. L. & Rosenthal, K. L. (1993). Mucosal immunity and protection after intranasal immunisation with recombinant adenovirus expressing herpes simplex virus glycoprotein B. Journal of Infectious Diseases 168, 622-629.
17. Gallichan, W. S., Johnson, D. C., Graham, F. L. & Rosenthal, K. L. (1995). Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus. Advances in Experimental Medical Biology 371B, 1581-1585.
18. Gaydos, C. A. & Gaydos, J. C. (1995). Adenovirus vaccines in the U. S. military. Military Medicine 160, 300-304.
19. Golding, S. M., Hedger, R. S. & Talbot, P. (1976). Radial immunodiffusion and serum-neutralization techniques for the assay of antibodies to swine vesicular disease. Research in Veterinary Science 20, 142-147.
20. Graham, F. L. & Prevec, L. (1991). Manipulation of adenovirus vectors. Methods in Molecular Biology 7, 109-128.
21. Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. (1977). Charac teristics of a human cell line transformed by DNA human adenovirus type 5. Journal of General Virology 36, 59-72.
22. Graham, F. L., Prevec, L., Schneider, M., Ghosh-Choudhury, G., McDermott, M. & Johnson, D. C. (1988). Cloning and expression of glycoprotein genes in human adenovirus vectors. In Technological Advances in Vaccine Development, pp. 243-253. Edited by E. L. Laskey. New York: A. R. Liss.
23. Hitt, M., Bett, A. J., Addison, C. L., Prevec, L. & Graham, F. L. (1995). Techniques for human adenovirus vector construction and characterization. Methods in Molecular Genetics 7, 13-30.
24. Hsu, K. H., Lubeck, M. D., Bhat, B. M., Bhat, R. A., Kostek, B., Selling, B. H., Mizutani, S., Davis, A. R. & Hung, P. P. (1994). Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model. Vaccine 12, 607-612.
25. Kadoi, K. (1997). Beneficial use of inactivated porcine adenovirus vaccine and antibody response of young pigs. New Microbiology 20. 89-91.
26. Lubeck, M. D., Natuk, R. J., Chengalvala, M., Chanda, P. K., Murthy, K. K., Murthy, S., Mizutani, S., Lee, S. G., Wade, M. S., Bhat, B. M. and others (1994). Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Research in Human Retroviruses 10, 1443-1449. [Erratum 11, 189.]
27. Martinez-Salas, E. & Domingo, E. (1995). Effect of the expression of the aphthovirus protease 3C on viral infection and gene expression. Virology 212, 111-120.
28. Mateu, M. G. (1995). Antibody recognition of picomaviruses and escape from neutralization: a structural view. Virus Research 38, 1-24.
29. Mateu, M. G., Martinez, M. A., Capucci, L., Andreu, D., Giralt, E., Sobrino, F., Brocchi, E. & Domingo, E. (1990). A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. Journal of General Virology 71, 629-637.
30. Mittal, S. K., McDermott, M. R., Johnson, D. C., Prevec, L. & Graham, F. L. (1993). Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Research 28, 67-90.
31. Mittal, S. K., Papp, Z., Tikoo, S. K., Baca-Estrada, M. E., Yoo, D., Benko, M. & Babiuk, L. A. (1996). Induction of systemic and mucosal immune responses in cotton rats immunised with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology 222, 299-309.
32. Pereira, H. G. (1981). Foot-and-mouth disease. In Virus Diseases of Food Animals, pp. 333-363. Edited by E. P. J. Gibbs. New York: Academic Press.
33. Porter, A. G. (1993). Picomavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. Journal of Virology 67, 6917-6921.
34. Prevec, L., Schneider, M., Rosenthal, K. L., Belbeck, L. W., Derbyshire, J. B. & Graham, F. L. (1989). Use of human adenovirus-based vectors for antigen expression in animals. Journal of General Virology 70, 429-434. [Corrigendum 70, 2539.]
35. Randrianarison-Jewtoukoff, V. & Perricaudet, M. (1995). Recombinant adenoviruses as vaccines. Biologicals 23, 145-157.
36. Rodriguez, A., Saiz, J. C., Novella, I. S., Andreu, D. & Sobrino, F. (1994). Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Virology 205, 24-33.
37. Roeder, P. L. & Le Blanc Smith, P. M. (1987). Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis. Research in Veterinary Science 43, 225-232.
38. Rose, J. K., Buonocore, L. & Whitt, A. (1991). A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. BioTechniques 10, 520-525.
39. Saiz, J. C., Cairo, J., Medina, M., Zuidema, D., Abrams, C., Belsham, G. J., Domingo, E. & Vlak, J. M. (1994). Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. Journal of Virology 68, 4557-4564.
40. Salt, J. S., Mulcahy, G. & Hitching, R. P. (1996). Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier" and "non-carrier" cattle. Epidemiology and Infection 117, 349-360.
41. Sanz-Parra, A., Blasco, R., Sobrino, F. & Ley, V. (1998). Analysis of the B and T cell response in guinea pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins. Archives of Virology 143, 389-398.
42. Snowdon, W. A. (1966). Growth of foot-and-mouth disease virus in monolayer cultures of calf thyroid cells. Nature 210, 1079-1080.
43. Strohmaier, K., Franze, R. & Adam, K. H. (1982). Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59, 295-306.
44. Sutmoller, P. & Gaggero, A. (1965). Foot- and mouth diseases carriers. Veterinary Record 77, 968-969.
45. Taboga, O., Tami, C., Carrillo, E., Nunez, J. I., Rodriguez, A., Saiz, J. C., Blanco, E., Valero, M. L., Roig, X., Camarero, J. A., Andreu, D., Mateu, M. G., Giralt, E., Domingo, E., Sobrino, F. & Palma, E. L. (1997). A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. Journal of Virology 71, 2606-2614.
46. Torres, J. M., Sanchez, C., Sune, C., Smerdou, C., Prevec, L., Graham, F. & Enjuanes, L. (1995). Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 213, 503-516.
47. Torres, J. M., Alonso, C., Ortega, A., Mittal, S., Graham, F. & Enjuanes, L. (1996). Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. Journal of Virology 70, 3770-3780.
48. Usherwood, E. J. & Nash, A. A. (1995). Lymphocyte recognition of picornaviruses. Journal of General Virology 76, 499-508.
49. van Lierop, M. J., Wagenaar, J. P., van Noort, J. M. & Hensen, E. J. (1995). Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. Journal of Virology 69, 4511-4514.
50. Xiang, Z. Q., Yang, Y., Wilson, J. M. & Ertl, H. C. (1996). A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219, 220-227.
51. Yarosh, O. K., Wandeler, A. I., Graham, F. L., Campbell, J. B. & Prevec, L. (1996). Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 14, 1257-1264.
52. Zinkernagel, R. M. (1996). Immunology taught by viruses. Science 271, 173-178.